World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
39124
World Ranking
12951
National Ranking
6623

Overview

Michael J. Morris is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on the medical field, with significant contributions in pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, oncology, cancer research, and molecular biology.

The scientist's work covers a variety of main topics, including:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Medical Imaging Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers

Michael J. Morris has published extensively in well-known venues, with frequent publications appearing in:

  • Journal of Clinical Oncology
  • European Urology
  • Clinical Cancer Research
  • Annals of Oncology
  • The Journal of Urology

Notable recent papers include:

  • Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, 2021, New England Journal of Medicine
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • The Lancet Commission on prostate cancer: planning for the surge in cases, 2024, The Lancet
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, European Urology
  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study, 2021, Clinical Cancer Research

Frequent co-authors collaborating with Michael J. Morris include:

  • Oliver Sartor
  • Johann S. de Bono
  • Karim Fizazi
  • Howard I. Scher
  • Susan Halabi

Best Publications

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

    Oliver Sartor;Johann de Bono;Kim N Chi;Karim Fizazi

  • Organoid cultures derived from patients with advanced prostate cancer

    Dong Gao;Ian Vela;Andrea Sboner;Phillip J Iaquinta

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

    Howard I Scher;Tomasz M Beer;Celestia S Higano;Aseem Anand

  • Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

    Toni K. Choueiri;Susan Halabi;Ben L. Sanford;Olwen Hahn

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

    Wassim Abida;Michael L. Cheng;Joshua Armenia;Sumit Middha

  • Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

    Daniel C. Danila;Michael J. Morris;Johann S. De Bono;Charles J. Ryan

  • Erratum: Integrative Clinical Genomics of Advanced Prostate Cancer

    Dan Robinson;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.

    Wassim Abida;Joshua Armenia;Anuradha Gopalan;Ryan Brennan

  • Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

    Susan Halabi;Chen-Yen Lin;W. Kevin Kelly;Karim S. Fizazi

  • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

    Scott T. Tagawa;Matthew I. Milowsky;Michael Morris;Shankar Vallabhajosula

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

    William Kevin Kelly;Susan Halabi;Michael Carducci;Daniel George

  • Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

    Susan Halabi;William Kevin Kelly;Hua Ma;Haojin Zhou

  • Tumor Localization of 16β-18F-Fluoro-5α-Dihydrotestosterone Versus 18F-FDG in Patients with Progressive, Metastatic Prostate Cancer

    Steven M Larson;Michael Morris;Ilonka Gunther;Brad Beattie

  • Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

    Toni K. Choueiri;Colin Hessel;Susan Halabi;Ben Sanford

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Incidence of nephrogenic systemic fibrosis at two large medical centers.

    Martin R. Prince;Honglei Zhang;Michael Morris;Jennifer L. MacGregor

Frequent Co-Authors

Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Susan Halabi
Susan Halabi Duke University
Eric J. Small
Eric J. Small University of California, San Francisco
Glenn Heller
Glenn Heller Memorial Sloan Kettering Cancer Center
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Jorge A. Carrasquillo
Jorge A. Carrasquillo Memorial Sloan Kettering Cancer Center
Daniel J. George
Daniel J. George Duke University
Celestia S. Higano
Celestia S. Higano University of Washington
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or supplementary career pathways is a smart move for anyone interested in medicine or healthcare. Online degrees offer convenient options to advance your education and broaden your career opportunities in this fast-growing field.

For those aiming to become advanced practice providers, attending the cheapest np school can help reduce overall educational costs—an important factor considering the rising expense of healthcare education.

Many prospective nurses start by researching online nursing programs that offer flexibility and affordability, allowing students to balance study with work or family commitments.

Current RNs interested in furthering their education often look at the average cost of rn to bsn programs to determine how to advance their credentials without incurring excessive debt.

For those interested in leadership, teaching, or research positions, pursuing online nursing phd programs can open doors to high-level roles with significant impact on healthcare systems and patient outcomes.

With numerous affordable and flexible options available, online degrees present valuable pathways for launching or advancing a healthcare career in the USA.

Best Scientists Citing Michael J. Morris

Trending Scientists

Recently Published Articles